Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/29029
Title: Incidence and risk factors for stroke following percutaneous coronary intervention.
Authors: Chan W.;Andrianopoulos N.;Thrift A.G. ;Clark D.J.;Brennan A.L.;Freeman M.;O'Brien J.;Sebastian M.;Shaw J.A.;Duffy S.J.;Reid C.M.;Dinh D.;Dawson L.P.;Cole J.A.;Lancefield T.F.;Ajani A.E.
Institution: (Dawson, Cole, O'Brien, Chan, Shaw, Duffy) Department of Cardiovascular Medicine, The Alfred Hospital, Melbourne, Australia (Dawson, Ajani) Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia (Cole, Chan, Duffy) Baker IDI Heart and Diabetes Institute, Melbourne, Australia (Lancefield, Clark) Department of Cardiology, Austin Health, Melbourne, Australia (Andrianopoulos, Brennan, Dinh, Reid, Duffy) Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia (Thrift) Stroke and Ageing Research, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia (Freeman) Department of Cardiology, Box Hill Hospital, Melbourne, Australia (Sebastian) Department of Cardiology, University Hospital Geelong, Geelong, Australia (Reid) School of Public Health, Curtin University, Perth, Australia
Issue Date: 17-Dec-2020
Copyright year: 2020
Publisher: SAGE Publications Inc.
Place of publication: United Kingdom
Publication information: International Journal of Stroke. 15 (8) (pp 909-922), 2020. Date of Publication: 01 Oct 2020.
Journal: International Journal of Stroke
Abstract: Background: Stroke rates and risk factors may change as percutaneous coronary intervention practice evolves and no data are available comparing stroke incidence after percutaneous coronary intervention to the general population. Aim(s): This study aimed to identify the incidence and risk factors for inpatient and subsequent stroke following percutaneous coronary intervention with comparison to age-matched controls. Method(s): Data were prospectively collected from 22,618 patients undergoing percutaneous coronary intervention in the Melbourne Interventional Group registry (2005-2015). The cohort was compared to the North-East Melbourne Stroke Incidence Study population-based cohort (1997-1999) and predefined variables assessed for association with inpatient or outpatient stroke. Result(s): Inpatient stroke occurred in 0.33% (65.3% ischemic, 28.0% haemorrhagic, and 6.7% cause unknown), while outpatient stroke occurred in 0.55%. Inpatient and outpatient stroke were associated with higher rates of in-hospital major adverse cardiovascular outcomes (p < 0.0001) and mortality (p < 0.0001), as well as 12-month mortality (p < 0.0001). Factors independently associated with inpatient stroke were renal impairment, ST-elevation myocardial infarction, previous stroke, left ventricular ejection fraction 30-45%, and female sex, while those associated with outpatient stroke were previous stroke, chronic lung disease, previous myocardial infarction, rheumatoid arthritis, female sex, and older age. Compared to the age-standardized population-based cohort, stroke rates in the 12 months following discharge were higher for percutaneous coronary intervention patients <65 years old, but lower for percutaneous coronary intervention patients >=65 years old. Conclusion(s): Risk of inpatient stroke following percutaneous coronary intervention appears to be largely associated with clinical status at presentation, while outpatient stroke relates more to age and chronic disease. Compared to the general population, outpatient stroke rates following percutaneous coronary intervention are higher for younger, but not older, patients.Copyright © 2020 World Stroke Organization.
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1177/1747493020912607
PubMed URL: 32248767 [http://www.ncbi.nlm.nih.gov/pubmed/?term=32248767]
ISSN: 1747-4930
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/29029
Type: Article
Subjects: out of hospital cardiac arrest
*percutaneous coronary intervention
priority journal
rheumatoid arthritis
severe renal impairment
sex difference
smoking
ST segment elevation myocardial infarction/th [Therapy]
very elderly
acetylsalicylic acid
anticoagulant agent
antithrombocytic agent
bivalirudin
fibrinogen receptor antagonist
heparin
inotropic agent/iv [Intravenous Drug Administration]
insulin/dt [Drug Therapy]
low molecular weight heparin
purinergic P2Y receptor antagonist
warfarin
intraaortic balloon pump
thrombectomy device
heart infarction/co [Complication]
adult
age
aged
all cause mortality
article
atrial fibrillation
Australian
bleeding/co [Complication]
bleeding/th [Therapy]
body mass
brain hemorrhage
brain ischemia
cardiogenic shock/co [Complication]
cardiovascular disease/co [Complication]
*cerebrovascular accident
chronic lung disease
comorbidity
controlled study
diabetes mellitus/dt [Drug Therapy]
dyslipidemia
female
heart left ventricle ejection fraction
hospital mortality
human
major clinical study
male
middle aged
moderate renal impairment
brain ischemia
cardiogenic shock / complication
cardiovascular disease / complication
*cerebrovascular accident
chronic lung disease
comorbidity
controlled study
diabetes mellitus / drug therapy
dyslipidemia
female
heart infarction / complication
heart left ventricle ejection fraction
hospital mortality
human
major clinical study
male
middle aged
moderate renal impairment
out of hospital cardiac arrest
*percutaneous coronary intervention
priority journal
rheumatoid arthritis
adult
sex difference
smoking
ST segment elevation myocardial infarction / therapy
very elderly
severe renal impairment
age
aged
all cause mortality
Article
atrial fibrillation
Australian
bleeding / complication / therapy
body mass
brain hemorrhage
Appears in Collections:Articles

Show full item record

Page view(s)

24
checked on Jun 29, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.